L. Roy Papp & Associates LLP Cuts Stake in SPDR S&P Biotech ETF (NYSEARCA:XBI)

L. Roy Papp & Associates LLP cut its holdings in SPDR S&P Biotech ETF (NYSEARCA:XBI) by 2.3% during the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 151,007 shares of the exchange traded fund’s stock after selling 3,607 shares during the period. SPDR S&P Biotech ETF accounts for 1.6% of L. Roy Papp & Associates LLP’s holdings, making the stock its 18th biggest holding. L. Roy Papp & Associates LLP owned 0.20% of SPDR S&P Biotech ETF worth $13,600,000 as of its most recent SEC filing.

A number of other large investors also recently added to or reduced their stakes in the business. Golden State Wealth Management LLC bought a new stake in shares of SPDR S&P Biotech ETF during the fourth quarter valued at approximately $29,000. Avior Wealth Management LLC grew its stake in SPDR S&P Biotech ETF by 393.6% during the fourth quarter. Avior Wealth Management LLC now owns 385 shares of the exchange traded fund’s stock valued at $35,000 after acquiring an additional 307 shares in the last quarter. Tidemark LLC increased its holdings in SPDR S&P Biotech ETF by 101.5% in the 3rd quarter. Tidemark LLC now owns 395 shares of the exchange traded fund’s stock valued at $39,000 after acquiring an additional 199 shares during the last quarter. Quintet Private Bank Europe S.A. purchased a new stake in SPDR S&P Biotech ETF in the 3rd quarter worth $40,000. Finally, ORG Wealth Partners LLC purchased a new stake in SPDR S&P Biotech ETF in the 3rd quarter worth $44,000.

SPDR S&P Biotech ETF Stock Down 1.4 %

Shares of SPDR S&P Biotech ETF stock opened at $89.05 on Wednesday. SPDR S&P Biotech ETF has a twelve month low of $81.14 and a twelve month high of $105.47. The business has a 50-day moving average price of $92.23 and a 200-day moving average price of $96.30. The firm has a market cap of $6.79 billion, a price-to-earnings ratio of 11.47 and a beta of 1.11.

About SPDR S&P Biotech ETF

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.